ReviewFrontiers in immunology2022

CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure.

Ana Carolina Caballero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.